Member Info for Nixynoo

The second placing of shares announced this afternoon are being admitted later than the initial placing announced this morning. I guess you will he told whether you were allocated shares in the first or second placing by Primebid

The video appears to have been recorded at some point in May; however it was only published today (4th June).

Thank you!

How do you know what profit they are making - I thought only sales figures had been released. Genuine question- thinking to invest and trying to work out what is holding the price down with a PE of less than 2...

Also... the FTSE is sea of red this morning

All very good points...

Mike B - I agree - should have read “anticipation of sky appearance” - spiked up early this morning and has since calmed down...

Very true PL - and I for one am hoping for some more useful RNS to land!

The quality of the annual report and presentation, the fact that they have appointed decent auditors who wouldn’t let unsubstantiated facts creep into the annual report have all given me a lot of comfort to continue to hold.

I don’t believe this is a MM tree shake, because I can buy easily but can’t sell. More likely they have a big sell order to fulfil... my finger hovered over the buy button a few times at sub £1.70, but I’m already heavily invested here...

I’m wondering if this is a consequence of the Sky interview of GDR that is currently taking place... it would seem that news on competitors is as much an issue as lack of news on our part... having got my fingers burnt at £1.05 only to have to panic buy back in at £1.30 the next morning, I won’t trade these again, especially having read in detail the annual report yesterday. Many people are stating that there is no covid product yet... I’m guessing that you don’t understand the significance of some of the statements in the Annual Report regarding the tie-ups and guaranteed revenue/cover of development costs in the oncology sphere or the fact that this is a company for whom the covid testing is an unforeseen bonus.

Just did a dummy buy for 10,000 shares and was offered 193.3.... perhaps a good time to top up!

Here we go! These are the inputs we need:
- Probability rapid covid-19 test is successfully released to mass demand: Agree binary, so model on 100% - if it doesn’t work then there will be a lot of hopes dashed!
- Average price per test sold (bearing in mind bulk orders may be heavily discounted): £12.... if the UK government ordered 68million if these tests and devised a testing strategy to have all residents test within a given window then we could potentially get close to eradicating Covid in this country for in the region of £800 million... given the covid borrowing is 2bn a day at the moment, this is a bargain for a 100% accurate test. At this volume, I would suspect they would want a discount of 50%!
- Cost of manufacturing per test: £1-£2
- Other costs per test e.g. distribution, admin: £2
- Avacta % of profit share with Medusa19: 60%
- Number of months of mass demand: globally, 12
- Average # sold per month of mass demand: Globally 50 million / month